Subnodal Correspondence of PSMA Expression and USPIO-MRI in Metastatic Pelvic Lymph Nodes in Prostate Cancer

被引:0
作者
Schilham, Melline Gabrielle Maria [1 ]
Somford, Diederik M. [2 ,3 ]
Veltien, Andor [1 ]
Zamecnik, Patrik [1 ]
Barentsz, Jelle O. [1 ,4 ]
Sedelaar, Michiel J. P. M. [2 ,5 ]
Kusters-Vandevelde, Heidi V. N. [6 ]
Gotthardt, Martin [1 ]
Rijpkema, Mark [1 ]
Scheenen, Tom W. J. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Imaging Nucl Med, GeertGrooteplein Zuid 10, NL-6525 GA Nijmegen, Netherlands
[2] Prosper Prostate Canc Clin, Eindhoven, Netherlands
[3] Canisius Wilhelmina Hosp, Dept Urol, Nijmegen, Netherlands
[4] Andros Clin, Med Imaging, Arnhem, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands
[6] Canisius Wilhelmina Hosp, Dept Pathol, Nijmegen, Netherlands
基金
美国国家卫生研究院; 英国惠康基金;
关键词
lymph node metastasis; prostate cancer; PSMA-PET/CT; USPIO-MRI; ex vivo imaging; DISSECTION;
D O I
10.1097/RLI.0000000000001046
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesTwo advanced imaging modalities used to detect lymph node (LN) metastases in prostate cancer patients are prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography and ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging (MRI). As these modalities use different targets, a subnodal comparison is needed to interpret both their correspondence and their differences. The aim of this explorative study was to compare ex vivo 111In-PSMA mu SPECT images with high-resolution 7 T USPIO mu MR images and histopathology of resected LN specimens from prostate cancer patients to assess the degree of correspondence at subnodal level.Materials and MethodsTwenty primary prostate cancer patients who underwent pelvic LN dissection were included and received USPIO contrast and 111In-PSMA. A total of 41 LNs of interest (LNOIs) were selected for ex vivo imaging based on gamma-probe detection or palpation. mu SPECT and mu MRI acquisition were performed immediately after resection. Overlay of mu SPECT images on MR images was performed, and the level of correspondence (LoC) between mu SPECT and mu MR findings was assessed according to a 4-point Likert classification scheme.ResultsForty-one LNOIs could be matched to an LN on ex vivo mu MRI. Coregistration of mu SPECT and USPIO-enhanced water-selective multigradient echo MR images was successful for all 41 LNOIs. Ninety percent of the lesions showed excellent correspondence regarding the presence of metastatic tissue and affected subnodal site (LoC 4; 37/41). In only 1 of 41 LNOIs, a small metastasis was misclassified by both techniques. Three LNOIs were classified as LoC 3 (7%) and 1 LNOI as LoC 2. All LoC 2 and LoC 3 lesions had PSMA-expressing metastases on final histopathologyConclusionsCoregistration of mu SPECT and USPIO-mu MRI showed excellent subnodal correspondence in the majority (90%) of LNs. Ex vivo imaging may thus help localize small cancer deposits within resected LNs and could contribute to improved interpretation of in vivo imaging of LNs.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 29 条
  • [1] Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection
    Baas, D. J. H.
    Schilham, M.
    Hermsen, R.
    de Baaij, J. M. S.
    Vrijhof, H. J. E. J.
    Hoekstra, R. J.
    Sedelaar, J. P. M.
    Kusters-Vandevelde, H. V. N.
    Gotthardt, M.
    Wijers, C. H. W.
    van Basten, J. P.
    Somford, D. M.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (01) : 65 - 70
  • [2] Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
    Birkhaeuser, Frederic D.
    Studer, Urs E.
    Froehlich, Johannes M.
    Triantafyllou, Maria
    Bains, Lauren J.
    Petralia, Giuseppe
    Vermathen, Peter
    Fleischmann, Achim
    Thoeny, Harriet C.
    [J]. EUROPEAN UROLOGY, 2013, 64 (06) : 953 - 960
  • [3] Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer
    Bukavina, Laura
    Luckenbaugh, Amy N.
    Hofman, Michael S.
    Hope, Tom
    Kamran, Sophia C.
    Murphy, Declan G.
    Yamoah, Kosj
    Ost, Piet
    [J]. EUROPEAN UROLOGY, 2023, 83 (06) : 521 - 533
  • [4] Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
    Czarniecki, Marcin
    Pesapane, Filippo
    Wood, Bradford J.
    Choyke, Peter L.
    Turkbey, Baris
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S453 - S461
  • [5] Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
    Dadfar, Seyed Mohammadali
    Roemhild, Karolin
    Drude, Natascha I.
    von Stillfried, Saskia
    Knuechel, Ruth
    Kiessling, Fabian
    Lammers, Twan
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2019, 138 : 302 - 325
  • [6] High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI A New Reading Algorithm Based on Node-to-Node Matched Histopathology
    Driessen, Daphne A. J. J.
    Zamecnik, Patrik
    Dijkema, Tim
    Pegge, Sjoert A. H.
    Van Engen-van Grunsven, Adriana C. H.
    Takes, Robert P.
    Kaanders, Johannes H. A. M.
    Scheenen, Tom W. J.
    [J]. INVESTIGATIVE RADIOLOGY, 2022, 57 (12) : 810 - 818
  • [7] Small Suspicious Lymph Nodes Detected on Ultrahigh-field Magnetic Resonance Imaging (MRI) in Patients with Prostate Cancer with High Risk of Nodal Metastases: The First In-patient Study on Ultrasmall Superparamagnetic Iron Oxide-enhanced 7T MRI
    Fortuin, Ansje
    van Asten, Jack
    Veltien, Andor
    Philips, Bart
    Hambrock, Thomas
    Johst, Soren
    Orzada, Stephan
    Hadaschik, Boris
    Quick, Harald
    Barentsz, Jelle
    Maas, Marnix
    Scheenen, Tom
    [J]. EUROPEAN UROLOGY, 2023, 83 (04) : 375 - 377
  • [8] Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
    Froehlich, Johannes M.
    Triantafyllou, Maria
    Fleischmann, Achim
    Vermathen, Peter
    Thalmann, George N.
    Thoeny, Harriet C.
    [J]. CONTRAST MEDIA & MOLECULAR IMAGING, 2012, 7 (03) : 346 - 355
  • [9] Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
    Harisinghani, MG
    Barentsz, J
    Hahn, PF
    Deserno, WM
    Tabatabaei, S
    van de Kaa, CH
    de la Rosette, J
    Weissleder, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) : 2491 - U5
  • [10] Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0 T:: Early experience
    Heesakkers, RAM
    Fütterer, JJ
    Hövels, AM
    van den Bosch, HCM
    Scheenen, TWJ
    Hoogeveen, YL
    Barentsz, JO
    [J]. RADIOLOGY, 2006, 239 (02) : 481 - 487